Orthopediatrics (NASDAQ:KIDS) released its quarterly earnings data on Thursday. The company reported ($0.18) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.17) by ($0.01), Briefing.com reports. Orthopediatrics had a negative return on equity of 12.92% and a negative net margin of 15.77%. The company had revenue of $20.74 million for the quarter, compared to the consensus estimate of $19.87 million. During the same period last year, the company earned ($0.15) EPS. Orthopediatrics’s revenue for the quarter was up 31.1% compared to the same quarter last year.
NASDAQ KIDS traded up $1.58 during trading hours on Friday, hitting $37.50. The company’s stock had a trading volume of 125,300 shares, compared to its average volume of 74,879. The company’s 50-day simple moving average is $36.29 and its two-hundred day simple moving average is $36.98. The company has a current ratio of 2.53, a quick ratio of 1.75 and a debt-to-equity ratio of 0.24. Orthopediatrics has a 52 week low of $25.11 and a 52 week high of $47.82. The company has a market capitalization of $560.98 million, a PE ratio of -39.06 and a beta of 0.23.
Several equities analysts recently weighed in on the stock. ValuEngine cut shares of Orthopediatrics from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Zacks Investment Research cut shares of Orthopediatrics from a “buy” rating to a “hold” rating in a research report on Saturday. BidaskClub cut shares of Orthopediatrics from a “buy” rating to a “hold” rating in a research report on Friday. Finally, Piper Jaffray Companies raised their price target on shares of Orthopediatrics from $40.00 to $44.00 and gave the company an “overweight” rating in a research report on Friday. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The stock has an average rating of “Buy” and an average target price of $44.40.
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard.
See Also: What does EPS mean?
Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.